Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
In a poster presentation at ASCO 2018, authors shared data from a recent study which suggest that testing and modulating the composition of the gut microbiome can have…
In the largest prospective study of angiogenesis in metastatic renal cell carcinoma (mRCC) patients to date, an Italian study yielded data that suggests sorafenib had no meaningful impact…
Researchers in South Korea have developed micro-robots (about 0.3 millimeters wide) that can be magnetically manipulated by physicians after injection to maximize stem cell delivery to the desired…
Researchers working within the University of New South Wales‘ (UNSW) Journey to the Centre of the Cell project have made great strides in 3D renderings that will allow…
Heat Biologics has devised a method intended to capture poly-antigens and present them to immunomodulatory mechanisms and revitalize the immune system, allowing it to target and annihilate cancer.
Current therapeutic options for non-small cell lung cancer (NSCLC) are ever-evolving with the possibility of solely immunotherapy-based treatment regimens on the near horizon for certain patients.
